Patent · US Active

Immunopotentiator

US10556004B2 · kind B2 · utility

0Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2014
Grant dateFeb 11, 2020
Priority date
Expiry dateFeb 23, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55583
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided an immunopotentiator comprising, as an active ingredient, a modified β-glucan which β-glucan and poly(hydroxy acid) are covalently bonded. The immunopotentiator can potently enhance the immunopotentiating effect of β-glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.